Bumrungrad Q3 2026 slides: record margins amid THB 15B expansion
Bumrungrad Hospital reported record profits and a robust 41.8% EBITDA margin for Q3 2026, despite facing challenges in the Middle Eastern market. The Bangkok-based international hospital operator completed a THB 15.2 billion expansion plan that will transform the institution over the next five years. The company's stock hovered near the upper limit of its 52-week range, trading at $199.
Bumrungrad's financial performance showcased exceptional efficiency, with a record EBITDA of THB 2,812 million and a net profit of THB 2,065 million. The hospital's revenue grew 2.8% year-over-year, with patient revenue reaching THB 6,676 million. The expansion plan, which will add approximately 31% more beds to the existing capacity, was detailed in the presentation, including new construction projects like the BIH Phuket hospital and the Bumrungrad Horizon Oncology Center.
The company's strategic focus on preventive care and longevity services aligns with its position as Southeast Asia's leading destination for quaternary medical care.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.